Download full-text PDF

Source
http://dx.doi.org/10.1002/bjs.1800721108DOI Listing

Publication Analysis

Top Keywords

rectal lymphoma
4
lymphoma radiation
4
radiation injured
4
injured bowel
4
rectal
1
radiation
1
injured
1
bowel
1

Similar Publications

Article Synopsis
  • - The study investigates how SARS-CoV-2 monoclonal antibody (mAB) therapy affects the immune response in five cancer patients infected with the virus, comparing them to non-mAB-treated controls.
  • - Blood samples were analyzed for various immune responses, revealing that all patients produced antibodies and T-cell responses similar to those of controls, despite some having B-cell deficiencies.
  • - The findings indicate that mAB therapy results in a robust immune response against SARS-CoV-2 in cancer patients, showing the potential for effective protective immunity even with underlying malignancies.
View Article and Find Full Text PDF

A 35-month-old Japanese Black cow was presented to a local veterinarian with a main complaint of premature labor. There was no swelling of lymph nodes on the body surface and no palpable mass on rectal examination. Although atypical lymphocytes were observed in the peripheral blood, no lymphocytosis was recorded.

View Article and Find Full Text PDF

Ethnopharmacological Relevance: Haizao, Sargassum, is widely used to treat goiter. Gancao, Glycyrrhizae radix et rhizome, is renowned for reducing toxicity or increasing effects in traditional Chinese medicine. As a classic herb pair, Haizao-Gancao (HG) is a commonly used and effective combined therapy for goiter.

View Article and Find Full Text PDF
Article Synopsis
  • Chemotherapy is crucial for cancer treatment but is often too expensive; the Indian government launched Jan Aushadhi (JAS) stores to provide affordable generic medicines.
  • The study aimed to compare the costs of chemotherapy regimens using JAS drugs, as well as the most and least expensive branded drugs in India.
  • Results showed substantial cost differences when using JAS drugs for chemotherapy across various types of cancers, indicating potential savings for patients.
View Article and Find Full Text PDF
Article Synopsis
  • Crohn's disease (CD) is linked to an increased risk of cancer, partly due to disease characteristics and immunosuppressive treatment; this study focuses on data from a northern Indian cohort to shed light on CD-related malignancies in Asia.
  • A total of 952 participants, with a mean age of 36.9 years and a follow-up period of 34 months, were analyzed, revealing a malignancy occurrence rate of 1.05%, which is 10.45 times higher than the general population.
  • By 30 years of diagnosis, the cumulative cancer risk for Indian individuals with CD was found to be 13.4%, covering various types of malignancies including bowel and extraintestinal cancers, but no cases of
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!